SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-17-000028
Filing Date
2017-01-03
Accepted
2017-01-03 11:49:40
Documents
1
Period of Report
2017-01-01

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 4416
  Complete submission text file 0001225208-17-000028.txt   5867
Mailing Address 575 HIGH STREET PALO ALTO CA 94301
Business Address 575 HIGH STREET PALO ALTO CA 94301 650 688 0818
Vivo Capital VIII, LLC (Reporting) CIK: 0001618789 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37558 | Film No.: 17500849

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations